Table 2.
Predictor | Estimate, β Value (95% CI) |
P Value |
---|---|---|
Intercept | .67 (− .24 to 1.58) | .14 |
Cell-associated RNA | .23 (.02–.43) | .03 |
Age | .02 (.008–.02) | <.001 |
pre-cART HIV-1 RNA | .14 (.03–.24) | .01 |
Race/ethnicity: Black | .21 (−.03 to .45) | .08 |
Race/ethnicity: Hispanic/other | .41 (.03–.79) | .03 |
Abbreviations: cART, combination antiretroviral therapy; CI, confidence interval; HIV-1, human immunodeficiency virus type 1.
aCovariates included in the initial model were age, sex, ethnicity/race, pretherapy plasma virus level, nadir and enrollment absolute CD4 T-cell count, years of therapy, and antiretroviral anchor. The covariates shown exclude those with a P value >.10.